Lonza Group AG (OTCMKTS:LZAGY) Sees Large Drop in Short Interest

Lonza Group AG (OTCMKTS:LZAGYGet Rating) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 2,400 shares, a decline of 35.1% from the March 31st total of 3,700 shares. Based on an average trading volume of 111,600 shares, the days-to-cover ratio is currently 0.0 days.

Shares of Lonza Group stock opened at $58.84 on Friday. The company’s fifty day simple moving average is $68.24 and its two-hundred day simple moving average is $73.53. Lonza Group has a 12-month low of $58.49 and a 12-month high of $86.31.

A number of equities research analysts have recently weighed in on the stock. Stifel Nicolaus upgraded shares of Lonza Group from a “hold” rating to a “buy” rating in a report on Thursday, February 10th. Zacks Investment Research downgraded shares of Lonza Group from a “hold” rating to a “sell” rating in a research note on Wednesday, March 30th. Morgan Stanley decreased their target price on shares of Lonza Group from CHF 800 to CHF 785 and set an “equal weight” rating on the stock in a research note on Monday, April 4th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Lonza Group from CHF 850 to CHF 900 in a research note on Tuesday, January 4th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Lonza Group currently has an average rating of “Buy” and an average price target of $592.00.

About Lonza Group (Get Rating)

Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals.

Further Reading

Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.